Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma

Increasing incidence coupled with poor prognosis and treatments that are virtually unchanged over the past 20 years have made the need for the development of novel therapeutics for hepatoblastoma imperative. PIM kinases have been implicated as drivers of tumorigenesis in multiple cancers, including...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Stafman, Laura L., Mruthyunjayappa, Smitha, Waters, Alicia M., Garner, Evan F., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Whelan, Kimberly, Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5978256/
https://ncbi.nlm.nih.gov/pubmed/29854306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25205
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi